Recent market reports tell us that the sterile injectable drugs market is set to grow in the coming years, driven by the increasing use of injectables in the treatment of cancer, diabetes, and cardiovascular diseases, among others. The COVID-19 pandemic has also contributed to this increasing demand and consequently, the market has seen a tightening of capacity.

For this reason, many biotech and pharma companies are now having to outsource the manufacturing of their drug products. Yet, many have limited-to-no experience of working with a CMO.

In this episode we have the pleasure of being joined by Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, a leading CMO with a focus on specialized sterile injectable manufacturing.